Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2022-02-24 Annual Report
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Preliminary Final Report 77 pages 1.2MB
Annual Report Classification · 95% confidence The document is an Appendix 4E and Preliminary Final Report for the year ended 31 December 2021, released by Anteris Technologies Ltd. It contains detailed financial data including revenues, net loss, cash flow, and a comprehensive Directors' Report with operating and financial review, financial position, and cash flow analysis. It also includes an Independent Auditor's Report and other financial statements. The document is lengthy (15,000 characters) and contains substantive financial data and analysis for a full fiscal year. Appendix 4E is a regulatory filing used in Australia to report preliminary final results, which is equivalent to an annual report. Given the detailed financial statements and comprehensive management discussion, this document fits the definition of an Annual Report (10-K equivalent). FY 2021
2022-02-24 English
Change in substantial holding 3 pages 157.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder (L1 Capital Pty Ltd) in Anteris Technologies Ltd. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2022-02-23 English
L1 Capital Exercises Options 1 page 167.4KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 23 February 2022 regarding L1 Capital exercising options to generate $5 million. It is a brief announcement about a financing event involving the exercise of unlisted options. There is no detailed financial report, no quarterly or annual results, no management discussion, no audit information, and no regulatory certification. The document is short (2057 characters) and focuses on a capital raising event through option exercise. This fits the category of Capital/Financing Update (CAP).
2022-02-22 English
Application for quotation of securities - AVR 10 pages 35.7KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities by Anteris Technologies Ltd, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, exercise prices, and the resulting issued capital. There is no financial performance data, management discussion, or earnings information. The document is a formal announcement related to capital changes, specifically the issuance and quotation of new shares following option exercises. This fits the category of Share Issue/Capital Change (SHA). The document length is over 10,000 characters, indicating it is a full announcement rather than a brief notice or a report publication announcement.
2022-02-22 English
Cleansing Notice 2 pages 167.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 23 February 2022 regarding the issuance of new fully paid ordinary shares following the conversion of unlisted options. It references compliance with the Corporations Act and provides details about the securities issued, including the number of shares and the dates of issue. The content focuses on a capital raising event through share issuance and includes a cleansing notice under section 708A(5)(e) of the Corporations Act. There is no financial report, earnings data, or management discussion. The document is a formal announcement about a capital transaction rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 3295 characters, which is consistent with an announcement rather than a full report.
2022-02-22 English
Ceasing to be a substantial holder 2 pages 963.9KB
Regulatory Filings
2022-02-15 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.